Viewing nowPregabalin 150 mg Capsule
Pregabalin 150mg
Hard capsule · Prescription medication
SaeHan Pharmaceutical Co., Ltd.

MFDS item code 201109159 · Approved 2011.10.25 · Insurance code 651300480
Treatment of peripheral and central neuropathic pain, adjunctive therapy for partial seizures in epilepsy, improvement of fibromyalgia.
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It is also effective as an adjunctive treatment for partial seizures in epilepsy, whether accompanied by secondary generalized symptoms or not. Additionally, it is used in the treatment of fibromyalgia, helping to alleviate patient symptoms. This drug is useful in various neurological disorders and contributes to improving the quality of life of patients.
This medication is taken orally in two divided doses daily, regardless of food. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose is 150 mg daily, which may be increased to 300 mg daily within 3 to 7 days, and then further increased to a maximum of 600 mg daily at intervals of 7 days. - Central neuropathic pain: Starting dose is 150 mg daily, which may be increased to 300 mg daily after one week.
For children under 12 years and adolescents aged 12 to 17, safety and efficacy data are insufficient, and use is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors and mental health issues such as depression during use, so patients and caregivers should inform healthcare professionals immediately if such symptoms occur. This medication should not be used in patients with hypersensitivity to its components, and diabetic patients may require adjustment of their blood glucose control medications due to weight gain. Allergic reactions such as angioedema may occur, so if symptoms such as swelling of the face or around the mouth appear, discontinue use immediately. Elderly patients may experience more severe dizziness or drowsiness, so caution is needed until they are accustomed to these symptoms when taking this medication. Vision may become blurred or change; if these symptoms occur, consult a healthcare professional. Abruptly discontinuing this medication may cause withdrawal symptoms such as insomnia, headache, and anxiety, so dosage adjustments should be made according to the healthcare provider's instructions. There is a risk of drug abuse, so patients with a history of drug abuse or mental disorders should take caution, and monitoring for unusual behavior is necessary. Patients with impaired kidney function may need dose adjustments for this medication. Patients with heart disease should exercise caution when taking this medication, especially those with congestive heart failure. Co-administration with opioid analgesics may increase the risk of central nervous system depression, so caution is needed. Patients with weak respiratory function or the elderly are at risk for severe respiratory depression, so dose adjustments and close monitoring are necessary. During early pregnancy, there is a risk of fetal malformation, so it is recommended that pregnant women do not take this medication, and women of childbearing age should use effective birth control methods. Breastfeeding women should consider stopping breastfeeding or discontinuing this medication as it may be passed into breast milk. It is safest to avoid dangerous activities such as driving or operating machinery until dizziness or drowsiness has resolved after taking this medication. Severe allergic reactions may occur on the skin, so if rash or skin abnormalities occur, discontinue use immediately and consult a healthcare professional. In case of overdose, symptoms may include mental confusion, drowsiness, depression, requiring immediate treatment. Keep this medication out of reach of children and do not transfer to other containers as maintaining quality is important.
Hives, angioedema, facial swelling, swelling around the mouth, upper airway swelling, cold sweat, severe swelling, chest tightness, difficulty breathing, severe rash with fever, blisters, skin peeling, pain in mouth/eyes mucosa, Stevens-Johnson syndrome, toxic epidermal necrolysis, symptoms similar to anaphylaxis, skin and mucous membrane syndrome, erythema multiforme, shortness of breath or difficulty breathing, asthma attacks, abnormal respiration accompanied by cough and fever, skin or...
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, maintaining a storage temperature between 15 and 30 degrees Celsius. Proper storage will help sustain the medication's effectiveness for a longer period.
Hard capsules with a white upper and a white lower part containing white or gray-white crystalline powder.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
SaeHan Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.